Network origin in Christopher J. Pazoles first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Novelos Therapeutics, Inc.
 Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI.
24
| Extinct | Pharmaceuticals: Major | 24 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Christopher J. Pazoles via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chairman Chairman Investor Relations Contact Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Wisconsin | College/University | Graduate Degree Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
| University of Michigan | College/University | Doctorate Degree Corporate Officer/Principal | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| New York University | College/University | Masters Business Admin Undergraduate Degree | |
| University of Wisconsin Carbone Cancer Center | Corporate Officer/Principal Director/Board Member | ||
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Biotechnology | Founder Investor Relations Contact | |
The Morgridge Institute for Research, Inc.
 The Morgridge Institute for Research, Inc. Miscellaneous Commercial ServicesCommercial Services The Morgridge Institute for Research, Inc. is a biosciences research institution. The private company is based in Madison, WI. The CEO of the company is Brad Schwartz. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
TomoTherapy, Inc.
 TomoTherapy, Inc. Medical SpecialtiesHealth Technology TomoTherapy, Inc. manufactures and provides radiation treatment systems for advanced radiation therapy. It provides radiation treatment services for cancer patients with its TomoTherapy Hi·Art System, which changes the intensity of the radiation beam so that it adapts to the shape of the tumor. The firm's system focuses on killing cancer cells while sparing healthy tissue. The company was founded by Thomas Rockwell Mackie and Paul J. Reckwerdt in 1997 and is headquartered in Madison, WI. | Medical Specialties | Director/Board Member Founder | |
SHINE Technologies LLC
 SHINE Technologies LLC Pharmaceuticals: MajorHealth Technology SHINE Technologies LLC manufactures radioisotopes for nuclear medicine. Its products include Molybdenum-99, Iodine-131, Iodine-125, and Xenon-133. The company was founded by Gregory R. Piefer and is headquartered in Monona, WI. | Pharmaceuticals: Major | Director/Board Member | |
Aris Industries, Inc.
 Aris Industries, Inc. Apparel/FootwearConsumer Non-Durables Aris Industries, Inc. engages in licensed trademarks. The firm's licensed products are sold primarily to department and specialty stores and national retail chains. The company was founded in 1947 and is headquartered in New York, NY. | Apparel/Footwear | Director/Board Member | |
OnLume, Inc.
 OnLume, Inc. Medical SpecialtiesHealth Technology OnLume, Inc. operates as a medical device company. It provides ergonomic solutions for precise fluorescence image-guided surgery. The company was founded by Adam Uselmann, Benjamin Titz, Andreas Velten, Kevin Eliceiri and Thomas Rockwell Mackie and is headquartered in Madison, WI. | Medical Specialties | Founder | |
BioIonix, Inc.
 BioIonix, Inc. Electronic Equipment/InstrumentsElectronic Technology BioIonix, Inc. supplies a breakthrough process equipment that solves advanced disinfection and oxidation problems. The firm's products are based on its proprietary and patented electrochemical processes along with its growing applications knowhow. The company was founded by James A. Tretheway and is headquartered in McFarland, WI. | Electronic Equipment/Instruments | Director/Board Member | |
Centaur Health Holdings, Inc.
 Centaur Health Holdings, Inc. Medical SpecialtiesHealth Technology Asto CT, Inc. engages in the development of x-ray computed tomography for imaging to prevent equine fractures for horses. It offers Equina, a multi-slice helical CT that allows simultaneous imaging of two limbs of a standing, sedated equine patient. The company was founded by Thomas Rockwell Mackie, Peter Muir, David L. Ergun, and Mark D. Markel in 2015 and is headquartered in Madison, WI. | Medical Specialties | Founder | |
| ACER THERAPEUTICS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Illuminated Holdings, Inc.
 Illuminated Holdings, Inc. Financial ConglomeratesFinance Illuminated Holdings, Inc. operates as an investment holding company. The company is headquartered in Janesville, WI. | Financial Conglomerates | Director/Board Member | |
Leo Cancer Care Ltd
 Leo Cancer Care Ltd Medical SpecialtiesHealth Technology Part of Asto CT, Inc., Leo Cancer Care Ltd is a British company that provides upright proton therapy, radiology, and photon therapy solutions for cancer treatment. The company is based in Smallfield, UK. The company's approach is built on research from across the globe, showing the benefits of upright patient positioning and a shift from machine rotation to patient rotation, which is set to change the face of radiation therapy for good. Leo Cancer Care was founded in 2018 by Stephen Kevin Towe and Thomas Rockwell Mackie, with Stephen Kevin Towe serving as the CEO since then. | Medical Specialties | Founder | |
DC Leo Cancer Care Ltd.
 DC Leo Cancer Care Ltd. Medical SpecialtiesHealth Technology Part of Asto CT, Inc., DC Leo Cancer Care Ltd. is a British company that aims to improve the quality of Radiation Therapy delivery and access to Radiation Therapy through the removal of gantries. The company is based in Smallfield, UK. The company's approach is built on research from across the globe showing the benefits of upright patient positioning, combined with a shift from machine rotation to patient rotation. Leo Cancer Care offers upright Proton Therapy, Radiology, and Photon Therapy solutions that provide key features and benefits to patients. The company's mission is to find a better way, a more human way to treat cancer. Leo Cancer Care was founded in 2018 by Thomas Rockwell Mackie. The CEO is Stephen Kevin Towe. | Medical Specialties | Founder | |
| Brandeis University | College/University | Undergraduate Degree | |
| Brandeis International Business School | College/University | Graduate Degree | |
| Framingham State College | College/University | Undergraduate Degree | |
| Simmons University | College/University | Masters Business Admin | |
| University of New Hampshire | College/University | Undergraduate Degree | |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Operating Officer | |
| Tufts University | College/University | Undergraduate Degree | |
| Medical Physics Foundation, Inc. | President | ||
| University of Alberta | College/University | Graduate Degree | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Analyst | |
Ren Pharmaceuticals, Inc.
 Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ren Pharmaceuticals was formed in the fall of 2006 with the aim of bringing together talented and experienced people who are passionate about building a cardio-renal/renal- focused drug development company. Ren Pharmaceuticals closed a Series A financing in November 2006 with Sanderling Ventures, Venrock Associates and Amgen Ventures as investors. The company's R&D is currently located in South San Francisco, California. | Pharmaceuticals: Major | Director/Board Member | |
BASF SA
 BASF SA Chemicals: Major DiversifiedProcess Industries Part of BASF SE, BASF SA is a Brazilian company that manufactures chemicals, paints, agricultural products and others. The company is based in São Paulo, Brazil. | Chemicals: Major Diversified | Sales & Marketing | |
Knoll AG
 Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The company is based in Haren, Germany. | Pharmaceuticals: Major | Sales & Marketing | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Chief Executive Officer | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
| ANACOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member | |
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Mc2 Therapeutics AS
 Mc2 Therapeutics AS Pharmaceuticals: MajorHealth Technology Mc2 Therapeutics is a Danish commercial stage biotech company that focuses on developing novel treatment paradigms for immune-mediated and inflammatory diseases. Mc2 Therapeutics is based in Denmark, specifically in Hørsholm, and has subsidiaries in the United Kingdom. The company is privately held and is developing a new standard of topical therapies for chronic inflammatory conditions using PAD™ technology. The company aims to release the full potential of novel topical drugs for the benefit of patients, physicians, payers, and societies. | Pharmaceuticals: Major | Director/Board Member | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member | |
RBNC Therapeutics, Inc.
 RBNC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology RBNC Therapeutics, Inc. develops and commercializes therapies for individuals with brain diseases. | Pharmaceuticals: Major | Chairman | |
Wisconsin Investment Partners LLC
 Wisconsin Investment Partners LLC Investment ManagersFinance Wisconsin Investment Partners LLC (Wisconsin Investment Partners) is a venture capital firm founded in 2000 by Dick Leazer and Terry Sivesind. The firm is headquartered in Madison, Wisconsin. | Investment Managers | Consultant / Advisor | |
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Epirium Bio, Inc. develops therapeutics for orphan and rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems. The company was founded in 2008 by Alan Stewart Maisel, Sundeep Dugar, and Francisco Villarreal and is headquartered in Los Altos Hills, CA. | Pharmaceuticals: Major | Chairman | |
EQRx International, Inc.
 EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Happy Health, Inc.
 Happy Health, Inc. Medical/Nursing ServicesHealth Services Happy Health, Inc. is a mission-driven technology company founded in 2019 and based in - that is committed to transforming mental health awareness. The company is based in Austin, TX and has subsidiaries in the United States. The company has developed the Happy Ring, which is the first wearable for your mind. The Happy Ring measures your stress and mood 24/7, providing real-time mood tracking that can change your life. | Medical/Nursing Services | Director/Board Member |
Statistics
International
| United States | 44 |
| United Kingdom | 3 |
| Canada | 2 |
| Brazil | 2 |
| Germany | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 11 |
| Finance | 4 |
| Commercial Services | 3 |
| Technology Services | 3 |
Operational
| Director/Board Member | 99 |
| Corporate Officer/Principal | 45 |
| Chief Executive Officer | 42 |
| Chairman | 42 |
| President | 33 |
Most connected contacts
| Insiders | |
|---|---|
| James Manuso | 30 |
| Paul Berns | 28 |
| John Niederhuber | 25 |
| John Neis | 22 |
| Thomas Mackie | 19 |
| David McWilliams | 19 |
| Simon Pedder | 19 |
| Stephen Hill | 18 |
| Michael J. Doyle | 16 |
| Joanne M. Protano | 7 |
| Jamey P. Weichert | 7 |
| George R. Vaughn | 6 |
| John Patrick Genn | 6 |
| Harry Palmin | 5 |
| Sim Fass | 5 |
- Stock Market
- Insiders
- Christopher J. Pazoles
- Company connections
